Dr.Mitsuo Oshimura
answered CTTE's
editors questions
Director of Chromosome Engineering Research Center Tottori University

Federal Law of Russian Federation “On protection of children from information harmful to their health and development

Hemabank - stem cell bank

FMBC named by А.I. Burnazian

Radio Moscow Echo, letters asking for help

Cellular therapy and transplantation

Hematopoiesis. Blood Stem Cell & Cell Therapy Trends

Regeneration of respiratory ways and lung tissues

Jazz Philharmonic Big Band

News

11.05.2013
Second Informational letter for VI Annual International Symposium «Current topics in gene and cell technologies»
Dear colleagues! Federal Medical-biological Agency “Burnasyan Federal Medical Biophysical Center” Human Stem Cell Institute Interregional public society of experts in cell technologies and regenerative medicine Welcome you on VI Annual International Symposium «Current topics in gene and cell technologies»
19.03.2013
VI Annual International Symposium «Current topics in gene and cell technologies»
Dear colleagues! Federal Medical-biological Agency “Burnasyan Federal Medical Biophysical Center” Human Stem Cell Institute Interregional public society of experts in cell technologies and regenerative medicine. Welcome you on VI Annual International Symposium «Current topics in gene and cell technologies»
18.02.2013
Dr.Mitsuo Oshimura - director of Chromosome Engineering Research Center answered CTTE editors questions
Dr.Mitsuo Oshimura - director of Chromosome Engineering Research Center answered CTTE editors questions
07.02.2013
Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy: a double blind, randomized, placebo-controlled trial
Umbilical cord blood therapy potentiated with erythropoietin for children with cerebral palsy. Dr. Min Young Kim has published the results of a double blind, randomized, placebo-controlled trial
13.12.2012
"Public" interview with professor Gerard Wagemaker
During 2 months everyone had had the opportunity to ask a question to Gerard Wagemaker, PhD, professor of Hematology, holding the Chair of Stem Cell Gene Therapy at Erasmus University Medical Center of Rotterdam, The Netherlands. Today we are publishing the results of this “public” interview.
Volume VIII №1, 2013 - The actual number
Reviews
Gomzikova M.O., Gaifullina R.F., Mustafin I.G., Chernov V.M., Miftahova Z.R., Galyavich A.S., Rizvanov A.A
Membrane microvesicles: biological properties and involvement in pathogenesis
Arutyunyan I.V., Kananykhina E.Y., Makarov A.V.
Role of VEGF-A165 receptors in angiogenesis
Original research
Goltsev A.N., Rassokha I.V., Dubrava T.G., Ostankova L.V., Ostankov M.V., Gordienko E.A., Safonov V.I., Zykova A.V.
Application of nanocomposite coatings for multipotent mesenchymal stromal cells cultivation technologies
Kyzlasov P.S., Voskanyan S.E., Paklina O.V.
Tissue reaction in experimental peritoneal damage during treatment miramistin
Zafranskaya M.M., Bogdan V.G., Demidchik Yu.E., Gain Yu.M., Bagatka S.S., Shelkovich S.E., Ivanchik G.I.
Comparative characteristic of immunomodulatory properties of human multipotent mesenchymal stromal cells and fibroblasts
Pirozhkov I.A., Glebova M.A., Canaeva M.D., Khrupina A.S., Smirnova S.A., Ivolgin D.A., Smolyaninov A.B., Pets L.
Finding of CCR5-Δ32 cord blood haemopoetic stem cells: opportunities and perspectives for treatment of patients with HIV-infection
Nasredinov A.S., Lavreshin A.V., Anisimov S.V., Vavilov V.N., Kurapeev D.I.
Decellularized human umbilical arteries as a potential scaffold for small diameter tissue engineered vascular grafts
Volchkov S.E., Shishkovsky I.V., Bairikov I.M.
Influence of porous three-dimensional implants from nitinol on culture of multipotent mesenchymal stromal cells
Kobzeva I.V., Astrelina T.A., Yakovleva M.V., Karpova E.E., Kruglova Y.A., Boyakova E.V., Shachpazyan N.R., Gomzyakov A.E.
Evaluation of the quality of cryopreserved umbilical cord blood before and after cryostorage BioArchive® in Stem cell bank of Moscow
Shishatskaya E.I., Nikolaeva E.D., Shumilova A.A., Shabanov A.V., Volova T.G.
Cultivation of multipotent mesenchymal bone marrow cells on matrixes made of resorbable bioplastotan
Dmitrieva R.I., Klukina M.A., Мinullina I.R., Anisimov S.V., Zaritskey A.Yu.
The adoption of expansion strategies of bone marrow derived mesenchymal stromal cells from patients with heart failure and co-morbidities
Clinical cases
Knyazev O.V., Parfenov A.I., Shcherbakov P.L., Ruchkina I.N., Khomeriki S.G., Konoplyannikov A.G.
Efficacy and safety of mesenchymal stromal cells of bone marrow in patients with refractory forms Crohn’s disease

Media arhive

ПИ №ФС77-46116 from August, 10 2011 г.
Registration certificate celltranspl.ru
ISSN: 1815-445X | Certificate of registration CTTE
Copyright 2005-2013 CTTE